Modelo de Cascada de Atención para la co-infección de las hepatitis virales para el cuidado continuo en personas con VIH/Sida

Simple item page
dc.creatorTapia, Leandro
dc.creatorPeña, Paola
dc.creatorManosalvas, Laura
dc.creatorPaulino-Ramírez, Robert
dc.date2019-11-25
dc.date.accessioned2020-09-09T19:44:00Z
dc.date.available2020-09-09T19:44:00Z
dc.descriptionIntroduction: Co-infections of viral hepatitis and HIV represent a risk due to their high transmissibility and com-plications. It is vitally important that barriers to access and management of HIV and Hepatitis B and C co-infections can be identified. The purpose of the study is to describe the cascade of attention for the preparation of viral hepatitis in people living with HIV/AIDS. Methods: The management and follow-up indicators of the patients currently monitored in first-level care clinics in Santo Domingo and Santiago were delimited. The data collected was analyzed from the written records of the patients in follow-up to evaluate the epidemiological and serological data that was obtained from the clinical files. Results: It was demonstrated that 100% of the patients were enrolled, 85.7% were considered as retained in care of HIV / HBV coinfection and only 71.4% received ART-based on Tenofovir. The cascade of care for HIV / HCV coinfection shows a linkage to care of 87.5% of patients, 75% were retained and none received treatment. Conclusions: Identifying the risk factors that influence the gaps in the cascade of care is essential to optimize the management and monitoring of coinfected patients, with special interest in those that might receive immediate treat-ment to prevent liver cytopathological sequelae.en-US
dc.descriptionIntroducción: las coinfecciones con hepatitis virales y el VIH representan un riesgo por su alta transmisibilidad y complicaciones. Es de vital importancia que se puedan identificar las barreras de acceso y manejo de las coinfeccio-nes del VIH y la Hepatitis B y C. El propósito del estudio es describir la cascada de atención para la coinfección de las hepatitis virales en personas viviendo con VIH/SIDA. Métodos: se delimitaron los indicadores de manejo y seguimiento de los pacientes monitoreados actualmente en clínicas de primer nivel de atención en Santo Domingo y Santiago. Los datos recopilados fueron analizados a partir de los registros escritos de los pacientes en seguimiento, para evaluar los datos epidemiológicos y serológicos que se obtuvieron de los archivos clínicos. Resultados: se demostró que un 100 % de los pacientes fueron enrolados, 85.7 % se consideraron como retenidos en el manejo de la coinfección VIH/VHB y solamente 71.4 % recibieron TARV basado en Tenofovir. La casca-da de atención para la coinfección VIH/VHC muestra un vínculo de 87.5 % de los pacientes, 75 % fueron retenidos y ninguno recibió tratamiento. Conclusión: la identificación de los factores de riesgo que influyen en las brechas de la cascada es fundamental para optimizar el manejo y monitoreo de los pacientes coinfec-tados, teniendo en cuenta que es preciso poder reconocer aquellos infectados para iniciar tratamiento de inmediato y así prever secuelas citopatológicas hepáticas.es-ES
dc.formatapplication/pdf
dc.formattext/html
dc.identifierhttps://revistas.intec.edu.do/index.php/cisa/article/view/1542
dc.identifier10.22206/cysa.2019.v3i3.pp35-41
dc.identifier.urihttps://repositoriobiblioteca.intec.edu.do/handle/123456789/2755
dc.languagespa
dc.publisherIntituto Tecnológico de Santo Domingo (INTEC)es-ES
dc.relationhttps://revistas.intec.edu.do/index.php/cisa/article/view/1542/2132
dc.relationhttps://revistas.intec.edu.do/index.php/cisa/article/view/1542/2122
dc.relation/*ref*/Organización de las Naciones Unidas. Resolución de la Asamblea General de las Naciones Unidas. Transformar nuestro mundo: la Agenda 2030 para el Resolución Desarrollo Sostenible. [21 de octubre de 2015]; consultado el 8 de agosto de 2017. Disponible en: http://www.un.org/ga/search/ view_doc.asp?symbol=A/RES/70/1&referer=/english/&Lang=S
dc.relation/*ref*/United Nations. (2019). Good health and well-be-ing. The Sustainable Development Goals Report The Sustainable Development Goals Report 2019, 26–29. doi: 10.18356/179bc73d-en
dc.relation/*ref*/Murray PR, Rosenthal KS, Pfaller MA. Micro-biología Médica. Barcelona: Elsevier; 2014.
dc.relation/*ref*/World Health Organization. (2016). Consol-idated guidelines on the use of antiretroviral drugs for treating and preventing Hiv infection (Vol. 2). Retrieved from https://www.who.int/hiv/pub/arv/arv-2016/en/
dc.relation/*ref*/World Health Organization. Number of people (allages) living with HIV Estimates by WHO region. GHO | Bycategory | Number of people (Allages) living with HIV - Estimatesby WHO region. [August, 02 2019; consultado el 18 de julio de 2017]. Available from http://apps.who.int/gho/data/view.main.22100WHO?lang=en (Number of people (allages) living with HIV Es-timatesby country. GHO | Bycategory | Number of people (Allages) living with HIV - Estimates-by country. http://apps.who.int/gho/data/node.main.620?lang=en
dc.relation/*ref*/Organización Mundial de la Salud 2017. Hep-atitis B. [19 de julio de 2019; consultado el 18 de julio de 2017]. Available from http://www.who.int/mediacentre/factsheets/fs204/es/
dc.relation/*ref*/Centers for Disease Control and Prevention 2018. Viral Hepatitis. Hepatitis B Questions and Answers for Health Professionals. [October 8, 2019; accessed October 6, 2018] Available from https://www.cdc.gov/hepatitis/hbv/hbv-faq.htm#general ().
dc.relation/*ref*/Jose-Abrego A, Panduro A, Fierro NA, Roman S. High prevalence of HBV infection, detection of subgenotypes F1b, A2, and D4, and differen-tial risk factors among Mexican risk populations with low socioeconomic status. J Med Virol. 2017;89: 2149–57.
dc.relation/*ref*/Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemi-ology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22: 7824–40.
dc.relation/*ref*/Bessone F, Brahm J, Bustios C, Cheinquer H, Contreras F, Díaz G, et al. Recomendaciones para el manejo de la Hepatitis C en América Latina. (1era. ed.) Lima: Asociación Latinoamericana para el estudio del Hígado (ALEH); 2018.
dc.relation/*ref*/NHS. Hepatitis C Treatment. [June 21, 2018; accessed October 22, 2018]. Available from https://www.nhs.uk/conditions/hepatitis-c/treatment/
dc.relation/*ref*/HIV/AIDS JUNPo, editor. UNAIDS. Glob-al AIDS Update. Geneva: United Nations; 2016.
dc.relation/*ref*/Ledesma J, Jimenez M, Caballero T, Adames R, et al. Guía de Atención de las Hepatitis Virales y sus Comorbilidades asociadas al VIH. (1era. ed.) Ministerio de Salud Pública; Junio 2018.
dc.relation/*ref*/WorldHealthOrganization. More than 2 million people coinfected with HIV and hepatitis C. [March 7 2016; accessed October 6, 2018]. Available from http://www.who.int/hiv/media-centre/news/hep-hiv-coinfected/en/
dc.relation/*ref*/Evashwick CJ. Creating a continuum. Thegoalis to provide an integrated system of care. Health-Prog.1989;70: 36–9, 56
dc.relation/*ref*/McMahon BJ. Editorial Commentary: Sliding Down the Cascade of Care for Chronic Hepa-titis B Virus Infection. ClinInfectDis. 2016;63: 1209–11.
dc.relation/*ref*/Viner K, Kuncio D, Newbern EC, Johnson CC. The continuum of hepatitis C testing and care. Hepatology. 2015;61: 783–9.
dc.relation/*ref*/Kutnick AH, Gwadz MV, Cleland CM, et al. It’s a Process: Reactions to HIV Diagnosis and Engagement in HIV Care among High-Risk Heterosexuals. Frontiers in PublicHealth. 2017;5: 100. doi:10.3389/fpubh.2017.00100
dc.relation/*ref*/Hickey MD, Odeny TA, Petersen M, et al. Spec-ification of implementation interventions to address the cascade of HIV care and treatment in resource-limited settings: a systematic review. ImplementationScience cience : IS. 2017;12: 102. doi:10.1186/s13012-017-06
dc.relation/*ref*/Ayieko J, Brown L, Anthierens S, et al. “Hurd leson the path to 90-90-90 and beyond”: Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. Costa AB, ed. PLoS ONE. 2018;13(8): e0202990. doi:10.1371/journal.pone.0202990.
dc.relation/*ref*/Tapia L, Pena P, Manosalvas L, Camilo A, Routy JP, Paulino-Ramirez R. Improving continuum of care in dominican republic for hiv-infected patients co-infected with hepatitis b and c. Amer Jour of Trop Med and Hyg 2018 jan 1, vol. 99, no. 4, pp. 620-620.
dc.rightsDerechos de autor 2019 Ciencia y Saludes-ES
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/4.0es-ES
dc.sourceScience and Health; Vol 3 No 3 (2019): Science and Health, september-december; 35-41en-US
dc.sourceCiencia y Salud; Vol. 3 Núm. 3 (2019): Ciencia y Salud, septiembre-diciembre; 35-41es-ES
dc.source2613-8824
dc.source2613-8816
dc.source10.22206/cysa.2019.v3i3
dc.subjectHIen-US
dc.subjectCascade of caren-US
dc.subjectHIVen-US
dc.subjectHBVen-US
dc.subjectHCVen-US
dc.subjectcoinfectionen-US
dc.subjectcascada de atenciónes-ES
dc.subjectVIHes-ES
dc.subjectVHBes-ES
dc.subjectVHCes-ES
dc.subjectcoinfecciónes-ES
dc.titleCare Continuum Model for Coinfection of Viral Hepatitis for the Continuing Care in people living with HIV / AIDSen-US
dc.titleModelo de Cascada de Atención para la co-infección de las hepatitis virales para el cuidado continuo en personas con VIH/Sidaes-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
Files
Collections
Articulos CS